Interest groups blamed for lacklustre price disclosure cuts

Price disclosure has not worked properly to reduce PBS costs, with pharmacy interest groups potentially to blame, a health economist has told the Senate hearing into pharmaceutical prices.

Appearing before the Senate Standing Committee on Community Affairs, Peter Breadon, health fellow at the Grattan Institute, told the Committee that the people losing out from the high cost of medicines were a widely